FinTrust Capital Advisors’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$81.3K Sell
200
-9
-4% -$3.29K 0.01% 473
2024
Q2
$67.1K Buy
209
+39
+23% +$12.7K 0.01% 470
2024
Q1
$56.7K Buy
170
+4
+2% +$1.22K 0.01% 484
2023
Q4
$44.9K Buy
166
+35
+27% +$8.65K 0.01% 520
2023
Q3
$32.2K Buy
+131
New +$35.8K 0.01% 555
2019
Q2
Sell
-2,523
Closed -$329K 1137
2019
Q1
$329K Buy
2,523
+43
+2% +$5.78K 0.14% 141
2018
Q4
$309K Buy
+2,480
New +$333K 0.15% 128

Other funds holding HCA

FinTrust Capital Advisors's HCA Position: Q3 2024 in Review

FinTrust Capital Advisors reduced its HCA Healthcare (HCA) stake by 4.3% in Q3 2024, selling an estimated $3.29K and leaving 200 shares worth $81.3K. The position accounts for 0.01% of the portfolio, ranked #473.

FinTrust Capital Advisors first reported a position in HCA in Q4 2018 and has held it in 7 quarters since. The position peaked at $329K in Q1 2019. 1,202 funds tracked by Wall St. Rank hold HCA as of Q3 2024.

  • FinTrust Capital Advisors held 200 shares of HCA Healthcare worth $81.3K as of Q3 2024.
  • FinTrust Capital Advisors sold 9 HCA Healthcare shares in Q3 2024, an estimated $3.29K.
  • HCA Healthcare made up 0.01% of FinTrust Capital Advisors's portfolio in Q3 2024, its #473 holding.
  • FinTrust Capital Advisors first reported a position in HCA Healthcare in Q4 2018 and has held it in 7 quarters since.
  • FinTrust Capital Advisors's HCA Healthcare position peaked at $329K in Q1 2019.
  • 1,202 funds tracked by Wall St. Rank held HCA Healthcare as of Q3 2024.

Based on FinTrust Capital Advisors's 13F filing for Q3 2024, filed 11 Oct 2024.